Received: 8 September 2020
Accepted: 7 May 2021
First Online: 8 September 2021
: A. Regev is a co-founder and equity holder of Celsius Therapeutics, an equity holder in Immunitas, and was a Scientific Advisory Board member of Thermo Fisher Scientific, Syros Pharmaceuticals, Neogene Therapeutics and Asimov until 31 July 2020. From 1 August 2020, A. Regev and O.R-R. are employees of Genentech. S.A.T. has consulted for Genentech and Roche, and is a remunerated member of Scientific Advisory Boards for GlaxoSmithKline, Biogen and Foresite Labs. J. Lundeberg is a scientific advisor for 10x Genomics. All other authors declare no competing interests.
Free to read: This content has been made available to all.